Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection.

Liam Townsend Gerard HughesColm KerrMary KellyRoisin O'ConnorEileen SweeneyCatriona DoyleRuth O'RiordanColm BerginCiaran Bannan

Published in: JAC-antimicrobial resistance (2020)

The rate of bacterial coinfection in SARS-CoV-2 is low. Despite this, prolonged courses of antimicrobial therapy were prescribed in our cohort. We recommend active antimicrobial stewardship in COVID-19 cases to ensure appropriate antimicrobial prescribing.

Keyphrases

sars cov
staphylococcus aureus
respiratory syndrome coronavirus
primary care
coronavirus disease
emergency department
stem cells
mesenchymal stem cells
intensive care unit
bone marrow